Montelukast in the Treatment of Allergic Rhinitis
Authors:
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 67 (6) , 887-901
Abstract
Cysteinyl-leukotrienes (CysLTs) are endogenous mediators of inflammation and play an important role in allergic airway disease by stimulating bronchoconstriction, mucus production, mucosal oedema and...Keywords
This publication has 102 references indexed in Scilit:
- The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trialsAnnals of Allergy, Asthma & Immunology, 2006
- Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivityAnnals of Allergy, Asthma & Immunology, 2006
- Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2005
- Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapyAnnals of Allergy, Asthma & Immunology, 2005
- The role of leukotrienes in allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2005
- Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studiesAnnals of Allergy, Asthma & Immunology, 2004
- Safety and Tolerability of Treatments for Allergic Rhinitis in ChildrenDrug Safety, 2004
- Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukastAnnals of Allergy, Asthma & Immunology, 2003
- Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984